New Delhi, Apr 4 (PTI) Biotechnology firm Biocon on Friday said its board has approved to raise up to Rs 600 crore in one or more tranches on a private placement basis.

The company's board has approved issuance of commercial papers up to an amount not exceeding Rs 600 crore in one or more tranches on private placement basis, the company said in a regulatory filing.

Also Read | TNUSRB SI Recruitment 2025: Notification Released For 1,299 Sub-Inspector Vacancies at tnusrb.tn.gov.in; Know Age Limit, Eligibility Criteria and Other Important Details.

It, however, did not disclose reasons for raising the capital.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)